Boehringer partnership to advance biologic for rare skin condition
18 July 2025 | By Catherine Eckford (European Pharmaceutical Review)
The new partnership between Boehringer Ingelheim and LEO Pharma aims to expand treatment access for more patients with generalised pustular psoriasis.